Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or...

Dalrada (DFCO). Our 11th and Latest Ten Bagger.

We've actually had many more than 11 ten-baggers, as we report on companies which aren't clients. This is our 11th client we...
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold...
Issam Radd

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR) Summary
Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Internet Stock Review

Stocks On The Move!

Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
Dalarada, Internet Stock Review

Discontinuing Coverage on Dalrada (DFCO).

We Are Temporarily Discontinuing Coverage on Dalrada Financial. Great little company and we're up 400%. But with the market...

Citius Pharma (CTXR) Updates Shareholders.

Citius Update Stem Cell Study Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
Stem Cell Stock Review

Old News, But Wow: Starr Foundation Reaffirms Support for Stem Cell Research with $50...

Someone is a Big Believer and Cutting Equally Big Checks! NEW YORK (April 4, 2019) — The Starr...

Latest article

Adding Asia Broadband (AABB) to WatchList.

Gold Backed Cryptocurrency Token. Adding Asia Broadband (AABB) $0.028 to the Watch List.

Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital. LIVE QUOTE

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so...